MSDs Keytruda granted FDA extension

MSD’s Keytruda granted FDA extension

The approval is based on results from the Phase III KEYNOTE-042 trial.

Original Article: MSD’s Keytruda granted FDA extension

More From BioPortfolio on "MSD’s Keytruda granted FDA extension"